A Case of Fulminant Meningococcemia: It Is All in the Complement

Eculizumab is a novel monoclonal antibody that inhibits complement-mediated hemolysis in patients with paroxysmal nocturnal hemoglobinuria (PNH). Complement deficiency is a well-known risk factor for meningococcal infection. We describe a case of a young patient with PNH treated with eculizumab who...

Full description

Saved in:
Bibliographic Details
Main Authors: Kellie L. Hawkins, Mariah Hoffman, Sonia Okuyama, Sarah E. Rowan
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Case Reports in Infectious Diseases
Online Access:http://dx.doi.org/10.1155/2017/6093695
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565794247016448
author Kellie L. Hawkins
Mariah Hoffman
Sonia Okuyama
Sarah E. Rowan
author_facet Kellie L. Hawkins
Mariah Hoffman
Sonia Okuyama
Sarah E. Rowan
author_sort Kellie L. Hawkins
collection DOAJ
description Eculizumab is a novel monoclonal antibody that inhibits complement-mediated hemolysis in patients with paroxysmal nocturnal hemoglobinuria (PNH). Complement deficiency is a well-known risk factor for meningococcal infection. We describe a case of a young patient with PNH treated with eculizumab who presented with a life-threatening case of nongroupable meningococcemia. As this new biologic agent becomes more widely prescribed, providers should be aware of the increased risk of meningococcemia. In addition to vaccination, providers may consider the use of oral penicillin for antibiotic prophylaxis against Neisseria meningitidis in these cases of functional complement deficiency.
format Article
id doaj-art-7b2d36cc4dc046a5ba5119081f3026a1
institution Kabale University
issn 2090-6625
2090-6633
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Case Reports in Infectious Diseases
spelling doaj-art-7b2d36cc4dc046a5ba5119081f3026a12025-02-03T01:06:39ZengWileyCase Reports in Infectious Diseases2090-66252090-66332017-01-01201710.1155/2017/60936956093695A Case of Fulminant Meningococcemia: It Is All in the ComplementKellie L. Hawkins0Mariah Hoffman1Sonia Okuyama2Sarah E. Rowan3Division of Infectious Disease, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USADenver Health and Hospital Authority, Denver, CO, USADenver Health and Hospital Authority, Denver, CO, USADivision of Infectious Disease, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USAEculizumab is a novel monoclonal antibody that inhibits complement-mediated hemolysis in patients with paroxysmal nocturnal hemoglobinuria (PNH). Complement deficiency is a well-known risk factor for meningococcal infection. We describe a case of a young patient with PNH treated with eculizumab who presented with a life-threatening case of nongroupable meningococcemia. As this new biologic agent becomes more widely prescribed, providers should be aware of the increased risk of meningococcemia. In addition to vaccination, providers may consider the use of oral penicillin for antibiotic prophylaxis against Neisseria meningitidis in these cases of functional complement deficiency.http://dx.doi.org/10.1155/2017/6093695
spellingShingle Kellie L. Hawkins
Mariah Hoffman
Sonia Okuyama
Sarah E. Rowan
A Case of Fulminant Meningococcemia: It Is All in the Complement
Case Reports in Infectious Diseases
title A Case of Fulminant Meningococcemia: It Is All in the Complement
title_full A Case of Fulminant Meningococcemia: It Is All in the Complement
title_fullStr A Case of Fulminant Meningococcemia: It Is All in the Complement
title_full_unstemmed A Case of Fulminant Meningococcemia: It Is All in the Complement
title_short A Case of Fulminant Meningococcemia: It Is All in the Complement
title_sort case of fulminant meningococcemia it is all in the complement
url http://dx.doi.org/10.1155/2017/6093695
work_keys_str_mv AT kellielhawkins acaseoffulminantmeningococcemiaitisallinthecomplement
AT mariahhoffman acaseoffulminantmeningococcemiaitisallinthecomplement
AT soniaokuyama acaseoffulminantmeningococcemiaitisallinthecomplement
AT saraherowan acaseoffulminantmeningococcemiaitisallinthecomplement
AT kellielhawkins caseoffulminantmeningococcemiaitisallinthecomplement
AT mariahhoffman caseoffulminantmeningococcemiaitisallinthecomplement
AT soniaokuyama caseoffulminantmeningococcemiaitisallinthecomplement
AT saraherowan caseoffulminantmeningococcemiaitisallinthecomplement